Literature DB >> 36175797

Protective effects of Acetobacter ghanensis against gliadin toxicity in intestinal epithelial cells with immunoregulatory and gluten-digestive properties.

Caglar Doguer1, Hande Akalan2, Nazan Tokatlı Demirok3, Berna Erdal4, Rafet Mete5, Turker Bilgen3.   

Abstract

PURPOSE: The aim of this study was to establish whether Acetobacter ghanensis, the probiotic characteristics of which were evaluated previously, attenuates gliadin-induced toxicity in intestinal epithelial cells with gluten-digestive and immunoregulatory properties.
METHODS: A co-culture model of human intestinal epithelial cell (Caco-2) monolayers on top of peripheral blood mononuclear cells (PBMCs) obtained from patients with celiac disease (CD) was established. The gluten-digestive properties of A. ghanensis were determined by checking bacterial growth in a medium containing gluten as the main nitrogen source. The mRNA levels of genes encoding TJ-associated proteins were measured by quantitative real-time PCR (qRT-PCR). The concentrations of IL-6 and TNFα were determined by enzyme-linked immunosorbent assay (ELISA).
RESULTS: We found that PT-gliadin disrupted intestinal barrier integrity by modulating the expression of TJ-associated genes encoding zonulin (increased by ~ 60%), zonula occludens-1 (ZO-1) (decreased by ~ 22%), and occludin (decreased by ~ 28%) in Caco-2 cells. Furthermore, PT-gliadin treatment in Caco-2 cells was associated with increased concentrations of IL-6 (~ 1.6-fold) and TNFα (~ twofold) from PBMCs. These modulatory effects of PT-gliadin, however, were suppressed when Caco-2 cells were subjected to A. ghanensis in the presence of PT-gliadin. As a factor underlying these protective effects, we showed that A. ghanensis could digest gluten peptides.
CONCLUSIONS: To our knowledge, the current study is the first to demonstrate that A. ghanensis improves intestinal barrier functions by attenuating the modulatory effects of PT-gliadin with immunoregulatory and gluten-digestive properties.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Acetobacter ghanensis; Caco-2 cells; Celiac disease; Probiotics

Year:  2022        PMID: 36175797     DOI: 10.1007/s00394-022-03015-6

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   4.865


  44 in total

1.  Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease.

Authors:  Chu-Young Kim; Hanne Quarsten; Elin Bergseng; Chaitan Khosla; Ludvig M Sollid
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-12       Impact factor: 11.205

Review 2.  The function of tissue transglutaminase in celiac disease.

Authors:  Antonio Di Sabatino; Alessandro Vanoli; Paolo Giuffrida; Ombretta Luinetti; Enrico Solcia; Gino Roberto Corazza
Journal:  Autoimmun Rev       Date:  2012-02-03       Impact factor: 9.754

3.  Probiotics-mixed messages.

Authors:  David R Mack
Journal:  Can Fam Physician       Date:  2005-11       Impact factor: 3.275

Review 4.  Systematic review: The evidence base for long-term management of coeliac disease.

Authors:  M L Haines; R P Anderson; P R Gibson
Journal:  Aliment Pharmacol Ther       Date:  2008-07-30       Impact factor: 8.171

5.  Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3.

Authors:  Karen M Lammers; Ruliang Lu; Julie Brownley; Bao Lu; Craig Gerard; Karen Thomas; Prasad Rallabhandi; Terez Shea-Donohue; Amir Tamiz; Sefik Alkan; Sarah Netzel-Arnett; Toni Antalis; Stefanie N Vogel; Alessio Fasano
Journal:  Gastroenterology       Date:  2008-03-21       Impact factor: 22.682

6.  HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope.

Authors:  H Quarsten; O Molberg; L Fugger; S N McAdam; L M Sollid
Journal:  Eur J Immunol       Date:  1999-08       Impact factor: 5.532

7.  Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity.

Authors:  Y van de Wal; Y Kooy; P van Veelen; S Peña; L Mearin; G Papadopoulos; F Koning
Journal:  J Immunol       Date:  1998-08-15       Impact factor: 5.422

8.  Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease.

Authors:  E M Nilsen; F L Jahnsen; K E Lundin; F E Johansen; O Fausa; L M Sollid; J Jahnsen; H Scott; P Brandtzaeg
Journal:  Gastroenterology       Date:  1998-09       Impact factor: 22.682

Review 9.  Celiac disease: from pathogenesis to novel therapies.

Authors:  Detlef Schuppan; Yvonne Junker; Donatella Barisani
Journal:  Gastroenterology       Date:  2009-09-18       Impact factor: 22.682

Review 10.  The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate.

Authors:  Shahryar Khaleghi; Josephine M Ju; Abhinav Lamba; Joseph A Murray
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.